The global market for Afatinib Dimaleate Tablets was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1589 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Afatinib Dimaleate Tablets Market

Afatinib dimaleate tablets are oral, small-molecule, irreversible tyrosine kinase inhibitors (TKIs) primarily used for treating patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Afatinib irreversibly inhibits EGFR, HER2, and HER4 signaling pathways, preventing cancer cell growth and proliferation. Clinical studies have shown that afatinib is highly effective as a first-line treatment for EGFR-mutant NSCLC, particularly in patients with Del19 and L858R mutations. The medication is typically administered orally once daily, with dosage adjustments based on individual patient conditions. Common side effects include diarrhea, skin rash, and stomatitis, and the drug should be used under medical supervision.

North American market for Afatinib Dimaleate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Afatinib Dimaleate Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Afatinib Dimaleate Tablets include Boehringer Ingelheim, Hansoh Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qingfeng Pharmaceutical Group, Qilu Pharmaceutical, Kelun Pharmaceutical, CSPC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Afatinib Dimaleate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Afatinib Dimaleate Tablets.

The Afatinib Dimaleate Tablets market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Afatinib Dimaleate Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Afatinib Dimaleate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Afatinib Dimaleate Tablets Market Report

Report Metric	Details
Report Name	Afatinib Dimaleate Tablets Market
Accounted market size in year	US$ 1063 million
Forecasted market size in 2031	US$ 1589 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	30mg 40mg Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Hansoh Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qingfeng Pharmaceutical Group, Qilu Pharmaceutical, Kelun Pharmaceutical, CSPC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Afatinib Dimaleate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Afatinib Dimaleate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Afatinib Dimaleate Tablets Market growing?

Ans: The Afatinib Dimaleate Tablets Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Afatinib Dimaleate Tablets Market size in 2031?

Ans: The Afatinib Dimaleate Tablets Market size in 2031 will be US$ 1589 million.

Who are the main players in the Afatinib Dimaleate Tablets Market report?

Ans: The main players in the Afatinib Dimaleate Tablets Market are Boehringer Ingelheim, Hansoh Pharmaceutical, Chia Tai Tianqing Pharmaceutical, Yangtze River Pharmaceutical, Qingfeng Pharmaceutical Group, Qilu Pharmaceutical, Kelun Pharmaceutical, CSPC

What are the Application segmentation covered in the Afatinib Dimaleate Tablets Market report?

Ans: The Applications covered in the Afatinib Dimaleate Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Afatinib Dimaleate Tablets Market report?

Ans: The Types covered in the Afatinib Dimaleate Tablets Market report are 30mg, 40mg, Others

1 Afatinib Dimaleate Tablets Market Overview

1.1 Product Definition

1.2 Afatinib Dimaleate Tablets by Type

1.2.1 Global Afatinib Dimaleate Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 30mg

1.2.3 40mg

1.2.4 Others

1.3 Afatinib Dimaleate Tablets by Application

1.3.1 Global Afatinib Dimaleate Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Afatinib Dimaleate Tablets Market Size Estimates and Forecasts

1.4.1 Global Afatinib Dimaleate Tablets Revenue 2020-2031

1.4.2 Global Afatinib Dimaleate Tablets Sales 2020-2031

1.4.3 Global Afatinib Dimaleate Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Afatinib Dimaleate Tablets Market Competition by Manufacturers

2.1 Global Afatinib Dimaleate Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Afatinib Dimaleate Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Afatinib Dimaleate Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Afatinib Dimaleate Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Afatinib Dimaleate Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Afatinib Dimaleate Tablets, Product Type & Application

2.7 Global Key Manufacturers of Afatinib Dimaleate Tablets, Date of Enter into This Industry

2.8 Global Afatinib Dimaleate Tablets Market Competitive Situation and Trends

2.8.1 Global Afatinib Dimaleate Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Afatinib Dimaleate Tablets Players Market Share by Revenue

2.8.3 Global Afatinib Dimaleate Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Afatinib Dimaleate Tablets Market Scenario by Region

3.1 Global Afatinib Dimaleate Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Afatinib Dimaleate Tablets Sales by Region: 2020-2031

3.2.1 Global Afatinib Dimaleate Tablets Sales by Region: 2020-2025

3.2.2 Global Afatinib Dimaleate Tablets Sales by Region: 2026-2031

3.3 Global Afatinib Dimaleate Tablets Revenue by Region: 2020-2031

3.3.1 Global Afatinib Dimaleate Tablets Revenue by Region: 2020-2025

3.3.2 Global Afatinib Dimaleate Tablets Revenue by Region: 2026-2031

3.4 North America Afatinib Dimaleate Tablets Market Facts & Figures by Country

3.4.1 North America Afatinib Dimaleate Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Afatinib Dimaleate Tablets Sales by Country (2020-2031)

3.4.3 North America Afatinib Dimaleate Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Afatinib Dimaleate Tablets Market Facts & Figures by Country

3.5.1 Europe Afatinib Dimaleate Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Afatinib Dimaleate Tablets Sales by Country (2020-2031)

3.5.3 Europe Afatinib Dimaleate Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Afatinib Dimaleate Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Afatinib Dimaleate Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Afatinib Dimaleate Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Afatinib Dimaleate Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Afatinib Dimaleate Tablets Market Facts & Figures by Country

3.7.1 Latin America Afatinib Dimaleate Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Afatinib Dimaleate Tablets Sales by Country (2020-2031)

3.7.3 Latin America Afatinib Dimaleate Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Afatinib Dimaleate Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Afatinib Dimaleate Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Afatinib Dimaleate Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Afatinib Dimaleate Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Afatinib Dimaleate Tablets Sales by Type (2020-2031)

4.1.1 Global Afatinib Dimaleate Tablets Sales by Type (2020-2025)

4.1.2 Global Afatinib Dimaleate Tablets Sales by Type (2026-2031)

4.1.3 Global Afatinib Dimaleate Tablets Sales Market Share by Type (2020-2031)

4.2 Global Afatinib Dimaleate Tablets Revenue by Type (2020-2031)

4.2.1 Global Afatinib Dimaleate Tablets Revenue by Type (2020-2025)

4.2.2 Global Afatinib Dimaleate Tablets Revenue by Type (2026-2031)

4.2.3 Global Afatinib Dimaleate Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Afatinib Dimaleate Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Afatinib Dimaleate Tablets Sales by Application (2020-2031)

5.1.1 Global Afatinib Dimaleate Tablets Sales by Application (2020-2025)

5.1.2 Global Afatinib Dimaleate Tablets Sales by Application (2026-2031)

5.1.3 Global Afatinib Dimaleate Tablets Sales Market Share by Application (2020-2031)

5.2 Global Afatinib Dimaleate Tablets Revenue by Application (2020-2031)

5.2.1 Global Afatinib Dimaleate Tablets Revenue by Application (2020-2025)

5.2.2 Global Afatinib Dimaleate Tablets Revenue by Application (2026-2031)

5.2.3 Global Afatinib Dimaleate Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Afatinib Dimaleate Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Company Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boehringer Ingelheim Afatinib Dimaleate Tablets Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Hansoh Pharmaceutical

6.2.1 Hansoh Pharmaceutical Company Information

6.2.2 Hansoh Pharmaceutical Description and Business Overview

6.2.3 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hansoh Pharmaceutical Afatinib Dimaleate Tablets Product Portfolio

6.2.5 Hansoh Pharmaceutical Recent Developments/Updates

6.3 Chia Tai Tianqing Pharmaceutical

6.3.1 Chia Tai Tianqing Pharmaceutical Company Information

6.3.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.3.3 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Product Portfolio

6.3.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.4 Yangtze River Pharmaceutical

6.4.1 Yangtze River Pharmaceutical Company Information

6.4.2 Yangtze River Pharmaceutical Description and Business Overview

6.4.3 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Product Portfolio

6.4.5 Yangtze River Pharmaceutical Recent Developments/Updates

6.5 Qingfeng Pharmaceutical Group

6.5.1 Qingfeng Pharmaceutical Group Company Information

6.5.2 Qingfeng Pharmaceutical Group Description and Business Overview

6.5.3 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Product Portfolio

6.5.5 Qingfeng Pharmaceutical Group Recent Developments/Updates

6.6 Qilu Pharmaceutical

6.6.1 Qilu Pharmaceutical Company Information

6.6.2 Qilu Pharmaceutical Description and Business Overview

6.6.3 Qilu Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Qilu Pharmaceutical Afatinib Dimaleate Tablets Product Portfolio

6.6.5 Qilu Pharmaceutical Recent Developments/Updates

6.7 Kelun Pharmaceutical

6.7.1 Kelun Pharmaceutical Company Information

6.7.2 Kelun Pharmaceutical Description and Business Overview

6.7.3 Kelun Pharmaceutical Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Kelun Pharmaceutical Afatinib Dimaleate Tablets Product Portfolio

6.7.5 Kelun Pharmaceutical Recent Developments/Updates

6.8 CSPC

6.8.1 CSPC Company Information

6.8.2 CSPC Description and Business Overview

6.8.3 CSPC Afatinib Dimaleate Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 CSPC Afatinib Dimaleate Tablets Product Portfolio

6.8.5 CSPC Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Afatinib Dimaleate Tablets Industry Chain Analysis

7.2 Afatinib Dimaleate Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Afatinib Dimaleate Tablets Production Mode & Process Analysis

7.4 Afatinib Dimaleate Tablets Sales and Marketing

7.4.1 Afatinib Dimaleate Tablets Sales Channels

7.4.2 Afatinib Dimaleate Tablets Distributors

7.5 Afatinib Dimaleate Tablets Customer Analysis

8 Afatinib Dimaleate Tablets Market Dynamics

8.1 Afatinib Dimaleate Tablets Industry Trends

8.2 Afatinib Dimaleate Tablets Market Drivers

8.3 Afatinib Dimaleate Tablets Market Challenges

8.4 Afatinib Dimaleate Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim

Hansoh Pharmaceutical

Chia Tai-Tianqing Pharmaceutical

Yangtze River Pharmaceutical

Qingfeng Pharmaceutical Group

Qilu Pharmaceutical

Kelun Pharmaceutical

CSPC

List of Tables

Table 1. Global Afatinib Dimaleate Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Afatinib Dimaleate Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Afatinib Dimaleate Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Afatinib Dimaleate Tablets Sales (kg) of Key Manufacturers (2020-2025)

Table 5. Global Afatinib Dimaleate Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Afatinib Dimaleate Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Afatinib Dimaleate Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Afatinib Dimaleate Tablets Average Price (US$/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Afatinib Dimaleate Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Afatinib Dimaleate Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Afatinib Dimaleate Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Afatinib Dimaleate Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Afatinib Dimaleate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Afatinib Dimaleate Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Afatinib Dimaleate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Afatinib Dimaleate Tablets Sales by Region (2020-2025) & (kg)

Table 18. Global Afatinib Dimaleate Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Afatinib Dimaleate Tablets Sales by Region (2026-2031) & (kg)

Table 20. Global Afatinib Dimaleate Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Afatinib Dimaleate Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Afatinib Dimaleate Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Afatinib Dimaleate Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Afatinib Dimaleate Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Afatinib Dimaleate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Afatinib Dimaleate Tablets Sales by Country (2020-2025) & (kg)

Table 27. North America Afatinib Dimaleate Tablets Sales by Country (2026-2031) & (kg)

Table 28. North America Afatinib Dimaleate Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Afatinib Dimaleate Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Afatinib Dimaleate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Afatinib Dimaleate Tablets Sales by Country (2020-2025) & (kg)

Table 32. Europe Afatinib Dimaleate Tablets Sales by Country (2026-2031) & (kg)

Table 33. Europe Afatinib Dimaleate Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Afatinib Dimaleate Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Afatinib Dimaleate Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Afatinib Dimaleate Tablets Sales by Region (2020-2025) & (kg)

Table 37. Asia Pacific Afatinib Dimaleate Tablets Sales by Region (2026-2031) & (kg)

Table 38. Asia Pacific Afatinib Dimaleate Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Afatinib Dimaleate Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Afatinib Dimaleate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Afatinib Dimaleate Tablets Sales by Country (2020-2025) & (kg)

Table 42. Latin America Afatinib Dimaleate Tablets Sales by Country (2026-2031) & (kg)

Table 43. Latin America Afatinib Dimaleate Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Afatinib Dimaleate Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Afatinib Dimaleate Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Afatinib Dimaleate Tablets Sales by Country (2020-2025) & (kg)

Table 47. Middle East and Africa Afatinib Dimaleate Tablets Sales by Country (2026-2031) & (kg)

Table 48. Middle East and Africa Afatinib Dimaleate Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Afatinib Dimaleate Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Afatinib Dimaleate Tablets Sales (kg) by Type (2020-2025)

Table 51. Global Afatinib Dimaleate Tablets Sales (kg) by Type (2026-2031)

Table 52. Global Afatinib Dimaleate Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Afatinib Dimaleate Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Afatinib Dimaleate Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Afatinib Dimaleate Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Afatinib Dimaleate Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Afatinib Dimaleate Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Afatinib Dimaleate Tablets Price (US$/g) by Type (2020-2025)

Table 59. Global Afatinib Dimaleate Tablets Price (US$/g) by Type (2026-2031)

Table 60. Global Afatinib Dimaleate Tablets Sales (kg) by Application (2020-2025)

Table 61. Global Afatinib Dimaleate Tablets Sales (kg) by Application (2026-2031)

Table 62. Global Afatinib Dimaleate Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Afatinib Dimaleate Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Afatinib Dimaleate Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Afatinib Dimaleate Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Afatinib Dimaleate Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Afatinib Dimaleate Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Afatinib Dimaleate Tablets Price (US$/g) by Application (2020-2025)

Table 69. Global Afatinib Dimaleate Tablets Price (US$/g) by Application (2026-2031)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Afatinib Dimaleate Tablets Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Hansoh Pharmaceutical Company Information

Table 76. Hansoh Pharmaceutical Description and Business Overview

Table 77. Hansoh Pharmaceutical Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 78. Hansoh Pharmaceutical Afatinib Dimaleate Tablets Product

Table 79. Hansoh Pharmaceutical Recent Developments/Updates

Table 80. Chia Tai Tianqing Pharmaceutical Company Information

Table 81. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 82. Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 83. Chia Tai Tianqing Pharmaceutical Afatinib Dimaleate Tablets Product

Table 84. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 85. Yangtze River Pharmaceutical Company Information

Table 86. Yangtze River Pharmaceutical Description and Business Overview

Table 87. Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 88. Yangtze River Pharmaceutical Afatinib Dimaleate Tablets Product

Table 89. Yangtze River Pharmaceutical Recent Developments/Updates

Table 90. Qingfeng Pharmaceutical Group Company Information

Table 91. Qingfeng Pharmaceutical Group Description and Business Overview

Table 92. Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 93. Qingfeng Pharmaceutical Group Afatinib Dimaleate Tablets Product

Table 94. Qingfeng Pharmaceutical Group Recent Developments/Updates

Table 95. Qilu Pharmaceutical Company Information

Table 96. Qilu Pharmaceutical Description and Business Overview

Table 97. Qilu Pharmaceutical Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 98. Qilu Pharmaceutical Afatinib Dimaleate Tablets Product

Table 99. Qilu Pharmaceutical Recent Developments/Updates

Table 100. Kelun Pharmaceutical Company Information

Table 101. Kelun Pharmaceutical Description and Business Overview

Table 102. Kelun Pharmaceutical Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 103. Kelun Pharmaceutical Afatinib Dimaleate Tablets Product

Table 104. Kelun Pharmaceutical Recent Developments/Updates

Table 105. CSPC Company Information

Table 106. CSPC Description and Business Overview

Table 107. CSPC Afatinib Dimaleate Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)

Table 108. CSPC Afatinib Dimaleate Tablets Product

Table 109. CSPC Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Afatinib Dimaleate Tablets Distributors List

Table 113. Afatinib Dimaleate Tablets Customers List

Table 114. Afatinib Dimaleate Tablets Market Trends

Table 115. Afatinib Dimaleate Tablets Market Drivers

Table 116. Afatinib Dimaleate Tablets Market Challenges

Table 117. Afatinib Dimaleate Tablets Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Afatinib Dimaleate Tablets

Figure 2. Global Afatinib Dimaleate Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Afatinib Dimaleate Tablets Market Share by Type: 2024 & 2031

Figure 4. 30mg Product Picture

Figure 5. 40mg Product Picture

Figure 6. Others Product Picture

Figure 7. Global Afatinib Dimaleate Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Afatinib Dimaleate Tablets Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Afatinib Dimaleate Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Afatinib Dimaleate Tablets Market Size (2020-2031) & (US$ Million)

Figure 14. Global Afatinib Dimaleate Tablets Sales (2020-2031) & (kg)

Figure 15. Global Afatinib Dimaleate Tablets Average Price (US$/g) & (2020-2031)

Figure 16. Afatinib Dimaleate Tablets Report Years Considered

Figure 17. Afatinib Dimaleate Tablets Sales Share by Manufacturers in 2024

Figure 18. Global Afatinib Dimaleate Tablets Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Afatinib Dimaleate Tablets Players: Market Share by Revenue in Afatinib Dimaleate Tablets in 2024

Figure 20. Afatinib Dimaleate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Afatinib Dimaleate Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Afatinib Dimaleate Tablets Sales Market Share by Country (2020-2031)

Figure 23. North America Afatinib Dimaleate Tablets Revenue Market Share by Country (2020-2031)

Figure 24. United States Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Afatinib Dimaleate Tablets Sales Market Share by Country (2020-2031)

Figure 27. Europe Afatinib Dimaleate Tablets Revenue Market Share by Country (2020-2031)

Figure 28. Germany Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Afatinib Dimaleate Tablets Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Afatinib Dimaleate Tablets Revenue Market Share by Region (2020-2031)

Figure 35. China Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Afatinib Dimaleate Tablets Sales Market Share by Country (2020-2031)

Figure 43. Latin America Afatinib Dimaleate Tablets Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Afatinib Dimaleate Tablets Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Afatinib Dimaleate Tablets Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Afatinib Dimaleate Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Afatinib Dimaleate Tablets by Type (2020-2031)

Figure 54. Global Revenue Market Share of Afatinib Dimaleate Tablets by Type (2020-2031)

Figure 55. Global Afatinib Dimaleate Tablets Price (US$/g) by Type (2020-2031)

Figure 56. Global Sales Market Share of Afatinib Dimaleate Tablets by Application (2020-2031)

Figure 57. Global Revenue Market Share of Afatinib Dimaleate Tablets by Application (2020-2031)

Figure 58. Global Afatinib Dimaleate Tablets Price (US$/g) by Application (2020-2031)

Figure 59. Afatinib Dimaleate Tablets Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Afatinib API Market Research Report 2024

Global Savolitinib Tablets Market Research Report 2024

Global Neratinib Maleate Tablets Market Research Report 2024

Global Lapatinib Ditosylate Tablets Market Research Report 2024

Global Ponatinib Tablets Market Research Report 2024

Erlotinib Hydrochloride Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Osimertinib Mesylate Tablets Market Research Report 2024

Global EGFR TKI Market Research Report 2024

Global EGFR TKI for Advanced NSCLC Market Research Report 2024

Global Filgotinib Tablets Market Research Report 2024

Icotinib Hydrochloride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lapatinib Ditosylate API Market Research Report 2025

Global Osimertinib Generics Market Research Report 2024

Anlotinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Icotinib API Market Research Report 2024

Global Ruxolitinib Drugs Market Research Report 2024

Global Brigatinib Tablet Market Insights Forecast to 2030

Imatinib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vandetanib Tablets Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions